Ximena Aguilera

Dr. Ximena Aguilera

Facultad de Medicina, Observatorio de Salud, Diego Portales University, Santiago, Región Metropolitana, Chile
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
LPLorena Porte
Lorena Porte
PLPaulette Legarraga
Paulette Legarraga
VVValeska Vollrath
Valeska Vollrath
XAXimena Aguilera
Ximena Aguilera
JMJosé M Munita
José M Munita
Thomas WeitzelThomas Weitzel
Thomas Weitzel
In the context of the Covid-19 pandemic, the development and validation of rapid and easy-to-perform diagnostic methods are of high priority. We evaluated a novel rapid antigen detection test (RDT) for SARS-CoV-2 in respiratory samples. The fluorescence immunochromatographic SARS-CoV-2 antigen test (Bioeasy Biotechnology Co., Shenzhen, China) was evaluated using universal transport medium with nasopharyngeal (NP) and oropharyngeal (OP) swabs from suspected Covid-19 cases. Diagnostic accuracy was determined in comparison to SARS-CoV-2 real time (RT)-PCR. A total of 127 samples were included; 82 were RT-PCR positive. Median patients' age was 38 years, 53.5% were male, and 93.7% were from the first week after symptom onset. Overall sensitivity and specificity were 93.9% (CI95% 86.5-97.4) and 100% (CI95% 92.1-100), respectively, with a diagnostic accuracy of 96.1% and Kappa coefficient of 0.9. Sensitivity was significantly higher in samples with high viral loads. The evaluated RDT showed a high sensitivity and specificity in samples mainly obtained during the first week of symptoms and with high viral loads, despite the use of a non-validated sample material. The assay has the potential to become an important tool for early diagnosis of SARS-CoV-2, particularly in situations with limited access to molecular methods.

17 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JMJ. Jaime Jaime Miranda
J. Jaime Jaime Miranda
VHVictor M. Herrera
Victor M. Herrera
JCJulio A. Chirinos
Julio A. Chirinos
LGLuis Gomez
Luis Gomez
PPPablo Perel
Pablo Perel
LBLeonelo E Bautista
Leonelo E Bautista
Limited knowledge on the prevalence and distribution of risk factors impairs the planning and implementation of cardiovascular prevention programs in the Latin American and Caribbean (LAC) region. Prevalence of hypertension, diabetes mellitus, abnormal lipoprotein levels, obesity, and smoking were estimated from individual-level patient data pooled from population-based surveys (1998–2007, n = 31,009) from eight LAC countries and from a national survey of the United States (US) population (1999–2004) Age and gender specific prevalence were estimated and age-gender adjusted comparisons between both populations were conducted. Prevalence of diabetes mellitus, hypertension, and low high-density lipoprotein (HDL)-cholesterol in LAC were 5% (95% confidence interval [95% CI]: 3.4, 7.9), 20.2% (95% CI: 12.5, 31), and 53.3% (95% CI: 47, 63.4), respectively. Compared to LAC region’s average, the prevalence of each risk factor tended to be lower in Peru and higher in Chile. LAC women had higher prevalence of obesity and low HDL-cholesterol than men. Obesity, hypercholesterolemia, and hypertriglyceridemia were more prevalent in the US population than in LAC population (31 vs. 16.1%, 16.8 vs. 8.9%, and 36.2 vs. 26.5%, respectively). However, the prevalence of low HDL-cholesterol was higher in LAC than in the US (53.3 vs. 33.7%). Major cardiovascular risk factors are highly prevalent in LAC region, in particular low HDL-cholesterol. In addition, marked differences do exist in this prevalence profile between LAC and the US. The observed patterns of obesity-related risk factors and their current and future impact on the burden of cardiovascular diseases remain to be explained.

27 March 2020 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
VLVernon J Lee
Vernon J Lee
MHMarc Ho
Marc Ho
CKChen Wen Kai
Chen Wen Kai
XAXimena Aguilera
Ximena Aguilera
DHDavid Heymann
David Heymann
AWAnnelies Wilder-Smith
Annelies Wilder-Smith

30 May 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
LSLorenzo Subissi
Lorenzo Subissi
AGAnne von Gottberg
Anne von Gottberg
LTLipi Thukral
Lipi Thukral
NWNathalie Worp
Nathalie Worp
BMBas Oude Munnink
Bas Oude Munnink
AAAnurag Agrawal
Anurag Agrawal

1 April 2007 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
CFCatterina Ferreccio
Catterina Ferreccio
ARAntonio Rollán
Antonio Rollán
PHPaul R. Harris
Paul R. Harris
CSCarolina Serrano
Carolina Serrano
AGAlessandra Gederlini
Alessandra Gederlini
AJAlejandro Jara
Alejandro Jara
Background and Aims: Chile ranks fifth in the world among countries with the highest incidence of gastric cancer. The aim was to quantify the association between Helicobacter pylori infection and gastric cancer mortality at the county of residence.

1 March 2013 in Revista Panamericana de Salud Pública
Verified
Journal Article
Closed access
PDF file
MAMacarena Hirmas Adauy
Macarena Hirmas Adauy
LALucy Poffald Angulo
Lucy Poffald Angulo
ASAnita María Jasmen Sepúlveda
Anita María Jasmen Sepúlveda
XAXimena Aguilera
Ximena Aguilera
IBIris Delgado Becerra
Iris Delgado Becerra
JMJeanette Vega Morales
Jeanette Vega Morales
To determine whether health care access barriers and facilitators cut across different populations, countries, and pathologies, and if so, at which stages of health care access they occur most frequently. A qualitative systematic review of literature published between 2000 and 2010 was undertaken drawing on six international sources: Fuente Académica, MEDLINE (full-text), Academic Search Complete (a full-text multidisciplinary academic database), PubMed, SciELO, and LILACS. Scientific appraisal guidelines from the Critical Appraisal Skills Programme Español (CASPe) and Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) were applied. Gray literature was also reviewed. From the review of scientific literature, 19 of 1 160 articles and 8 of 12 gray literature documents were selected. A total of 230 barriers and 35 facilitators were identified in countries with different contexts and degrees of development. The 230 barriers were classified according to the Tanahashi framework: 25 corresponded to availability, 67 to access, 87 to acceptability, and 51 to contact. Most of the barriers were related to acceptability and access. The facilitating elements that were identified had to do with personal factors, the provider-client relationship, social support, knowledge about diseases, and adaptation of the services to patients. The barriers and facilitators were seen mostly in people who initiated contact with the health systems, and they occurred at all stages of health care access. Only a few of the studies looked at people who did not initiate contact with the health services. The barriers and facilitators identified were socially determined and largely a reflection of existing social inequities in the countries. To reduce or eliminate them, joint action with other non-health sectors will be necessary.